137 related articles for article (PubMed ID: 37438387)
1. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue.
Kim SC; Cho YE; Shin YK; Yu HJ; Chowdhury T; Kim S; Yi KS; Choi CH; Cha SH; Park CK; Ku JL
Sci Data; 2023 Jul; 10(1):448. PubMed ID: 37438387
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
[TBL] [Abstract][Full Text] [Related]
3. Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing.
Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F
OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106
[TBL] [Abstract][Full Text] [Related]
4. Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity.
LeBlanc VG; Trinh DL; Aslanpour S; Hughes M; Livingstone D; Jin D; Ahn BY; Blough MD; Cairncross JG; Chan JA; Kelly JJP; Marra MA
Cancer Cell; 2022 Apr; 40(4):379-392.e9. PubMed ID: 35303420
[TBL] [Abstract][Full Text] [Related]
5. High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models.
Yost SE; Pastorino S; Rozenzhak S; Smith EN; Chao YS; Jiang P; Kesari S; Frazer KA; Harismendy O
PLoS One; 2013; 8(2):e56185. PubMed ID: 23441165
[TBL] [Abstract][Full Text] [Related]
6. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.
Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D
Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.
Patil V; Pal J; Somasundaram K
Oncotarget; 2015 Dec; 6(41):43452-71. PubMed ID: 26496030
[TBL] [Abstract][Full Text] [Related]
8. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.
Hodgson JG; Yeh RF; Ray A; Wang NJ; Smirnov I; Yu M; Hariono S; Silber J; Feiler HS; Gray JW; Spellman PT; Vandenberg SR; Berger MS; James CD
Neuro Oncol; 2009 Oct; 11(5):477-87. PubMed ID: 19139420
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
[TBL] [Abstract][Full Text] [Related]
11. Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing.
Virk SM; Gibson RM; Quinones-Mateu ME; Barnholtz-Sloan JS
PLoS One; 2015; 10(5):e0124178. PubMed ID: 25950952
[TBL] [Abstract][Full Text] [Related]
12. Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma.
Oh YT; Cho HJ; Kim J; Lee JH; Rho K; Seo YJ; Choi YS; Jung HJ; Song HS; Kong DS; Seol HJ; Lee JI; Yoon Y; Kim S; Nam DH; Joo KM
PLoS One; 2014; 9(8):e103327. PubMed ID: 25084005
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
[TBL] [Abstract][Full Text] [Related]
15. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
16. Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
Saadeh FS; Morsi RZ; El-Kurdi A; Nemer G; Mahfouz R; Charafeddine M; Khoury J; Najjar MW; Khoueiry P; Assi HI
PLoS One; 2020; 15(11):e0242793. PubMed ID: 33237934
[TBL] [Abstract][Full Text] [Related]
17. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
18. Identification of a panel of genes as a prognostic biomarker for glioblastoma.
Wang F; Zheng Z; Guan J; Qi D; Zhou S; Shen X; Wang F; Wenkert D; Kirmani B; Solouki T; Fonkem E; Wong ET; Huang JH; Wu E
EBioMedicine; 2018 Nov; 37():68-77. PubMed ID: 30341039
[TBL] [Abstract][Full Text] [Related]
19. Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
Jones DC; Scanteianu A; DiStefano M; Bouhaddou M; Birtwistle MR
PLoS One; 2018; 13(1):e0190664. PubMed ID: 29342193
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
